Mithu Maheswaranathan, MD Profile Banner
Mithu Maheswaranathan, MD Profile
Mithu Maheswaranathan, MD

@MithuRheum

Followers
7,126
Following
897
Media
163
Statuses
1,685

Rheumatologist at Duke 🧑🏽‍💻💉🏥 | Creator of Rheum OnePagers | Infographics • Lupus • Health Literacy | Tweets are my own.

North Carolina, USA
Joined March 2020
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Understanding ANAs, Antinuclear Antibodies — with @AnnKumfer ▶ What does a +ANA mean? ▶ What is the significance of the ANA titer/pattern? ▶ What rheumatic diseases and non-rheumatic diseases are associated with a +ANA? #MedTwitter #Rheumatology #ANA
Tweet media one
16
235
699
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 Myositis Specific Antibodies (MSAs): Clinical Features and Treatment for #Myositis /IIM 💪🏽 💪🏻Proximal Muscle Weakness 🫁 Interstitial Lung Disease 🤚🏽 Cutaneous [Dermatomyositis] #RheumTwitter #DermTwitter #PulmTwitter #MedEd
Tweet media one
14
257
696
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🆕 2023 ACR Guidelines for Management of Interstitial Lung Disease ( #ILD ) in Systemic Autoimmune Rheumatic Diseases 🫁 🔸 Screening & Monitoring Recs 🔸 Treatment Guidelines ILD/RP-ILD #RheumTwitter #PulmTwitter #MedTwitter #MedX
Tweet media one
11
273
652
@MithuRheum
Mithu Maheswaranathan, MD
7 months
🆕 #Vasculitis Demystified: An Approach to Systemic Vasculitides 🔥 • often characterized by SIZE of vessel • multi-system involvement: 🫁 Pulmonary 🫘 Renal 🤚🏽 Skin 👁️ Ocular #RheumTwitter #MedTwitter #MedX
Tweet media one
12
189
528
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 ACR 2021 Guidelines for Treatment of #RheumatoidArthritis 💊 🔴: strong recommendation 🟡: conditional recommendation 🔗:
Tweet media one
12
188
512
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 2022 ACR Guidelines for Vaccines in Patients with Rheumatic & MSK Diseases, PART 1 💉 #RheumTwitter #Rheumatology
Tweet media one
8
157
488
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 NIH Guidelines for COVID-19 Treatment in High-Risk Patients (including immunocompromised) in the Outpatient Setting Outpatient Rx Recommendations: 1️⃣ Paxlovid PO 2️⃣ Sotrovimab IV 3️⃣ Remdesivir IV 4️⃣ Molnupiravir PO #RheumTwitter #IDTwitter #Omicron
Tweet media one
9
201
459
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕OnePager on Hemophagocytic Lymphohistiocytosis (HLH) / Macrophage Activation Syndrome (MAS), created w/ @nickmmark ☔️ Cytokine Storm 🫁 Multi-Organ Failure 🌡️ Fever 🩸 Cytopenias/↑ Ferritin 🦠 Infection, Autoimmune, Cancer #MedTwitter   #FOAMed #RheumTwitter #HemeTwitter
Tweet media one
13
130
412
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Let’s Review the Scleroderma Mimics, a high-yield topic for #RheumBoards ! #RheumTwitter #DermTwitter
Tweet media one
6
115
354
@MithuRheum
Mithu Maheswaranathan, MD
7 months
It’s official !! Excited to announce that I have been promoted to Assistant Professor of Medicine 🧑🏽‍🏫🎉🥳 Thank you to all who made this possible AND to the #MedTwitter community 🙏🏻
Tweet media one
36
6
334
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Check out this new #ICUOnePager on Pulmonary Renal Syndromes (PRS) in collaboration w/ @nickmmark ! 🫁 Learn about an approach to PRS with a focus on ANCA Vasculitis vs GBM, autoimmune & other causes of PRS, DAH and more! #FOAMed #PulmTwitter #RheumTwitter #MedTwitter
Tweet media one
9
101
327
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 #Rheumatology Secrets & Pearls at #ACR22 | By Dr. @JKolfenbach & Dr. John Stone ( @MGHrheumatology ) 📚 Unique Pearls to Know: 💊 Reducing Steroids; PPI & MMF 🦵 Scleroderma Mimics 🫁 FVC/DLCO Ratio for ILD vs PAH 👁️ Inflammatory Eye Dz 🤰🏽 Changes in Pregnancy: C3/4, UPC, sCr
Tweet media one
Tweet media two
6
118
308
@MithuRheum
Mithu Maheswaranathan, MD
11 months
📌 2023 ACR Guidelines on Interstitial Lung Disease (ILD) at #ACR23 🫁 Screening Recommendations ⚠️ Risk Factors for ⇡Risk of ILD 🔑 Keys to Interpret Guidelines 🗣️Presented by @DrBernstein @SindhuJohnson5 @sclerodermaUM #RheumTwitter #InterstitialLungDisease #PulmTwitter
Tweet media one
3
128
312
@MithuRheum
Mithu Maheswaranathan, MD
3 years
#ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin Audience Vote 🗳: What would you add to mycophenolate first? Belimumab 71%, Voclosporin 29% #ACRAmbassador @ACRheum Summary of Pros & Cons of Each⬇️
Tweet media one
10
107
288
@MithuRheum
Mithu Maheswaranathan, MD
3 years
#ACR21 Rheumatology Secrets & Pearls: @JKolfenbach & Dr. Stone 📚 Unique Pearls Discussed ⬇️ 🩺 Auscultate bruits on the back 💊 Oxypurinol levels 🍓 Strawberry-like gingivitis 👃 Human neutrophil elastase (HNE) ♥️ Coronary aneurysm in IgG4-RD @ACRheum #ACRAmbassador
Tweet media one
Tweet media two
6
135
283
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 2022 ACR/AAHKS Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective THA/TKA 🦴💊 #RheumTwitter #OrthoTwitter @ACRheum @AAHKS
Tweet media one
6
119
280
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Clinical Year in Review | Presented by Dr. Carol Langford at #ACR22 🌟 Review the Most Important Clinical Research Studies in the Past Year in #Rheumatology ! 💫
Tweet media one
9
109
275
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🆕 Learn about Giant Cell Arteritis (GCA), a systemic vasculitis! Signs/Symptoms: 🤕 Temporal Headache  👁️ Visual Changes/Loss 👄 Jaw Claudication 🩸 ↑ Inflammatory Markers (ESR/CRP) 👵🏽 Age ≥ 50 years old #MedTwitter   #RheumTwitter    #NeuroTwitter #MedEd
Tweet media one
2
80
259
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Latest in Lupus Treatment at #ACR23 • Dr. Dall’Era & Dr. Furie • Approach to Lupus Nephritis 🫘 • Treating Non-Renal SLE / Skin #Lupus #RheumTwitter #Rheumatology
Tweet media one
6
114
259
@MithuRheum
Mithu Maheswaranathan, MD
8 months
🆕 Approach to Myositis (Inflammatory Myopathies) 🪄 💪🏽 Proximal Muscle Weakness 🖐️ Cutaneous (Gottron’s), Raynaud’s 🫁 Interstitial Lung Disease #RheumTwitter #MedTwitter #Myositis
Tweet media one
7
78
258
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Rheumatology Guidance for 3rd Dose (Booster) COVID-19 Vaccines | 8.19.21 Patients with Rheumatic Diseases can use this @RheumOnePagers to see if eligible for a booster & determine if medications qualify ⬇️
Tweet media one
10
104
245
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Systemic Lupus Erythematosus Disease Manifestations 1️⃣ Signs & Symptoms of Lupus 2️⃣ 2019 ACR/EULAR Classification Criteria for SLE In Collaboration with @AriellaStudies #MedTwitter #Lupus #Rheum
Tweet media one
Tweet media two
0
78
227
@MithuRheum
Mithu Maheswaranathan, MD
3 years
I’m incredibly excited to announce I will be starting on faculty @dukemedicine as an attending Rheumatologist this July! Thank you to everyone — friends & family, my residency/fellowship PDs & mentors — who supported me over the years. Looking forward to this new chapter! 🥳
40
2
227
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Statin Myopathy: Important Topic for Rheumatologists & Cardiologists! Fantastic Review from #ACR22   ♥ Differentiate Statin-Associated Toxic Myopathy from HMGCR Autoimmune Necrotizing Myopathy #RheumTwitter #CardsTwitter #MedTwitter #MedEd
Tweet media one
5
79
213
@MithuRheum
Mithu Maheswaranathan, MD
3 years
#ACR21 Clinical Year In Review Fantastic Overview by @karen_kc123 #ACRAmbassador @ACRheum
Tweet media one
7
60
191
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Excited to announce my new project @RheumOnePagers is live!🥳 Looking forward to creating more infographics and visual abstracts in #Rheumatology ! 📚 Website:
24
24
185
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Today is my last day of fellowship culminating 11 years of training! ☑️ 4 Years of Medical School ☑️ 4 Years of Residency #MedPeds ☑️ 3 Years of #Rheum Fellowship Now officially a rheumatologist! 🥳
Tweet media one
24
1
186
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🆕 2020 ACR Guidelines for Management of Reproductive Health in Patients w/ Rheum & MSK Diseases 🤰🏽 🔸 Pregnancy Counseling 🔸 Meds in Pregnancy/Breastfeeding 🔸 Male Medication Safety for Conception #RheumTwitter #OBTwitter #ReproRheum #MedX
Tweet media one
5
76
181
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Clinical Year in Review at #ACR23 By @philseo ( @jhrheumatology ) Review some of the most impactful scientific studies in #Rheumatology in the past year! 🍕
Tweet media one
1
70
181
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Managing #Gout : How to Manage Acute vs Chronic Gout Thank you to @AnnKumfer for collaborating on this and check out her tweetorial below! ⬇️ #MedTwitter #MedStudentTwitter #Rheumatology
Tweet media one
3
57
175
@MithuRheum
Mithu Maheswaranathan, MD
2 years
#ACR22 Lupus Line-Up: Difficult to Treat Lupus Cases Fantastic Session by Prof David Isenberg & Dr. Maria Dall'Era ❓ Deciding Belimumab vs Voclosporin 💉 Role of Combining Biologics in SLE 🫘 Changing Rx Paradigm for #LupusNephritis #Lupus   #RheumTwitter #NephTwitter
Tweet media one
1
72
173
@MithuRheum
Mithu Maheswaranathan, MD
2 years
#ACR22 The Jury on JAKs: Future of JAKi in Rheumatic Diseases | presented today by Dr. Jon Giles 📝 Review ORAL Surveillance Data ♥️ CV Risks & Risk Stratification 🛑 Malignancy Risk 🦠 Other: Infection, Zoster, PE/VTE #Rheumatology #RheumTwitter
Tweet media one
2
69
171
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Learn about #VEXAS , a new adult-onset autoinflammatory syndrome ⬇️ #MedTwitter #Rheumatology
Tweet media one
6
61
169
@MithuRheum
Mithu Maheswaranathan, MD
5 months
🆕 Let’s Learn about Sarcoidosis! Created with @mwsharp5 ⭐️ Sarcoidosis = inflammatory condition characterized by NON-necrotizing granulomas • multi-system involvement 🫁🫀🧠👁️ • April is Sarcoidosis Awareness Month! #RheumTwitter #PulmTwitter #MedX
Tweet media one
3
53
160
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 COVID-19 Vaccines for Immunocompromised Individuals 💉 🌟 New CDC Guidance Recommends a 4th Vaccine (Booster) *3 Months* after the 3rd Shot [in those who are Immunocompromised] ⬇️ Thank you Dr. Rebecca Sadun for reviewing! #RheumTwitter #OncTwitter #MedTwitter   #PedsTwitter
Tweet media one
7
62
153
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic & MSK Diseases 💉 #RheumTwitter #Rheumatology Updated Version Released 6/15/21 ⬇️ 🔗:
Tweet media one
1
71
144
@MithuRheum
Mithu Maheswaranathan, MD
2 months
🆕 Visual Abstract with @HealioRheum 🟢 Lymphadenopathy in #Rheum • Compare LAD in SLE, RA, SjD, sarcoid, IgG4-RD • Identify red flags for malignancy • Recognize features of Castleman's 📖 by Stefano Rodolfi  @DrPujaMehta1 @DavidFajgenbaum et al 🔗:
Tweet media one
3
62
147
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 OnePager on #PsoriaticArthritis ✋ Inflammatory Oligo/Polyarthritis 👁️ Inflammatory Eye Disease 🦵 Psoriasis 💅🏽 Psoriatic Nail Lesions 🫀 ↑ Risk for Cardiovascular Disease #MedTwitter #RheumTwitter #DermTwitter #MedEd #Psoriasis
Tweet media one
5
56
138
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Visual Abstract for the #COVaRiPAD Study PrePrint by @alhkim & Team 💉 Humoral Responses after both doses of mRNA-based COVID-19 Vaccines in 133 Patients with Chronic Inflammatory Diseases (CID) #MedTwitter #RheumTwitter #Immunology #VisualAbstract
Tweet media one
11
59
139
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 ACR/VF 2021 Guidelines for Treatment & Management of #Vasculitis Part 1: Giant Cell Arteritis (GCA), Takayasu Arteritis (TAK) and Polyarteritis Nodosa (PAN) 🔗 (GCA/TAK): 🔗 (PAN):
Tweet media one
2
63
129
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Just found out I passed my ABIM #Rheumatology Board Exam! 🥳
12
0
127
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 Updated 2021 ACR Guidance for Adjusting Immunomodulatory Therapy with the COVID-19 Vaccine in Patients with Rheumatic & MSK Diseases Discussed at #ACR21 COVID-19 Hub! V4 Link:
Tweet media one
5
57
120
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Handout on Digital Medical Education Resources — from my talk on SoMe in #MedEd at the 2023 #APDIM conference @AAIMOnline 🦠 @febrilepodcast 🧠 @neudrawlogy 🫁 @OnePagerICU @PulmPEEPs 🫀 @CardioNerds 🧪 @RheumOnePagers
Tweet media one
5
40
117
@MithuRheum
Mithu Maheswaranathan, MD
11 months
👨‍⚖️ The Great Debate: should we use advanced therapies / biologics at disease onset in PMR & GCA? #ACR23 By Dr. Robert Spiera & Dr. Phil Seo @philseo #Vasculitis #PMR #GCA
Tweet media one
2
44
111
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🆕 Use of Sarilumab in Refractory PMR: SAPHYR Trial | Visual Abstract 🎨 🎲 Phase 3 RCT: Sarilumab vs Placebo 💉 Sarilumab: ⇡ sustained remission, ⇣ cumulative steroid 🥇 1st ever FDA approved medication for PMR #RheumTwitter #Rheumatology #PolymyalgiaRheumatica
Tweet media one
3
30
104
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Celebrating #LupusAwarenessMonth with #SelenaGomez @LupusResearch Read the Full Interview Q&A here ⬇️
Tweet media one
Tweet media two
1
28
94
@MithuRheum
Mithu Maheswaranathan, MD
3 years
COUNTDOWN to #RheumBoards 📚 I will be posting some tips and tricks for high-yield board topics! First up, Periodic Fever Syndromes! Trying to remember # days of fever? • FMF = 3 letters = 3d max • Hyper IgD = ~7 letters = 7d max • TRAPS = don’t fall into trap! >7 days
Tweet media one
2
19
92
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 #VisualAbstract - AURORA1, Phase 3 RCT of Voclosporin vs. Placebo (+MMF) for Lupus Nephritis in @TheLancet #RheumTwitter #NephTwitter #Lupus
Tweet media one
3
36
91
@MithuRheum
Mithu Maheswaranathan, MD
3 years
#ACR21 Clinical Review of ILD by Dr. Kristin Highland Approach to SSc-ILD (and often how she approaches CTD-ILD): how to consider incorporation of nintedanib and tocilizumab after focuSSced and SENSCIS Trials ↓ #Scleroderma #RheumTwitter #PulmTwitter
Tweet media one
2
30
82
@MithuRheum
Mithu Maheswaranathan, MD
3 years
As #ACR21 comes to a close, time for some thank you's! First, I am so honored to be able to present this work on #telemedicine on behalf of @rheum_covid with Dr. Eugenia Chock & coauthors @SynceNerd_Carli @rashmi @egeli_bugra @Drbeckyg @hausmannMD @rheum_cat @emilysirotich
Tweet media one
Tweet media two
3
8
80
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🔥 New Visual Abstract in Collaboration with @HealioRheum 💫 🫁🫘 Rituximab vs Cyclophosphamide for Induction in GPA: which therapy was more likely to achieve remission in Granulomatosis with Polyangiitis? 📖 Article by: Puéchal et al, @TerrierBen #RheumTwitter #Vasculitis
Tweet media one
3
15
81
@MithuRheum
Mithu Maheswaranathan, MD
1 year
⭐️ New Visual Abstract with @HealioRheum 🫀 Antiphospholipid Antibodies & Future Incident CV Events: aPL IgA positivity is associated with ⬆️ risk for future ASCVD events ❤️‍🩹🧠 📖 Article by: Zuo et Al @RayZuoMD @jasonsknight @DrDavidKarp #RheumTwitter #CardsTwitter #APS
Tweet media one
3
30
75
@MithuRheum
Mithu Maheswaranathan, MD
3 months
🦋 Visual Abstract with @HealioRheum 🟢 Glucocorticoid Dosing in #Lupus Nephritis: Impact of GC Dose on Renal Response, Infections and Mortality • Systematic Review & Meta-Analysis 📖 by @DrGabrielFP @AliDuarteMD et al, A&R 🔗: #Rheum #LupusNephritis
Tweet media one
2
28
70
@MithuRheum
Mithu Maheswaranathan, MD
2 years
2022 ACR Guidelines for Vaccines in Patients with Rheumatic & MSK Diseases, PART 2 🔽
Tweet media one
3
27
67
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🔥 New Visual Abstract in Collaboration with @HealioRheum 🫁 Is PJP Prophylaxis overprescribed in patients with SLE on immunosuppressant medications? 📖 Article by: Boone et al, @BarnadoLab #RheumTwitter #IDTwitter #PulmTwitter
Tweet media one
2
25
62
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Had a few requests to take 📸 of my handouts from my FIT Roundtable on Graphics, and promised I’d post them on here! #ACR23 Tips for More Effective Graphics in Posters/Talks: • Use less text; ⬆️ graphics/images • Avoid blocks of text, bulleted lists • Spice it up 🌶️
Tweet media one
1
14
63
@MithuRheum
Mithu Maheswaranathan, MD
4 months
🆕 Visual Abstract with @HealioRheum 🟢 CD19 CAR-T Cell Therapy in Rheumatic Autoimmune Disease • Pts w/ SLE, IIM, SSc • CAR-T Cell therapy was safe/effective, all pts achieved disease remission 📖 by Muller et al, NEJM 🔗: #CARTCell #RheumTwitter
Tweet media one
3
19
58
@MithuRheum
Mithu Maheswaranathan, MD
2 years
✨ Check out our new #RheumMadness x @RheumOnePagers Bracket Infographic! 🏀📟 📖 Review Most Pivotal Studies in Rheum 🖥️ Read Scouting Reports Online 🏀 *1 Week Left to Submit Bracket* 📆 Bracket Due: Wed, Mar 22 at 11:59pm EST Thank you #RheumMadness Team & @DavidLeverenz !
Tweet media one
4
24
57
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🚨 Are you an #URM medical student interested in Rheumatology (especially Peds, IM or #MedPeds )? 🗣 Duke Rheum is excited to sponsor 3 URiM MS4 students for a visiting #Rheumatology rotation: 📆 2 wks Adult / 2 wks Peds 🏠 Housing & Travel Stipend Provided #MedStudentTwitter
Tweet media one
5
23
55
@MithuRheum
Mithu Maheswaranathan, MD
8 months
Enjoyed speaking at the 2024 NC ACP Meeting on Rheumatology for the PCP! 🎤 Covered inflammatory vs non-inflammatory pain and appropriate laboratory testing & interpretation (including ANA, RF/CCP, HLA-B27)! #NCACP24 #Rheumatology #ACP24
Tweet media one
Tweet media two
1
3
56
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Excited to help moderate this session on Use of Social Media in #Rheumatology at #ACR22 !!! 🖥️ Speakers: @rheum_cat & @EBRheum
Tweet media one
5
11
56
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 COVID-19 Vaccines for Immunocompromised Individuals 💉 🌟 CDC Guidance Recommends a *5th* Vaccine (Booster) in those who are #Immunocompromised ⬇️ Thanks Dr. Rebecca Sadun for reviewing! #RheumTwitter #OncTwitter
Tweet media one
0
30
55
@MithuRheum
Mithu Maheswaranathan, MD
1 year
Had fun speaking today at the 2023 APDIM (Association of Program Directors in IM) meeting on Use of Novel #SocialMedia strategies in #MedEd Thanks for having me! #APDIMFall23
Tweet media one
Tweet media two
3
1
55
@MithuRheum
Mithu Maheswaranathan, MD
2 years
As #ACR22 ends, I am so thankful for this conference & our lovely Rheum community. I presented my first poster as a MS2 med student at ACR 2012) & 10 yrs later, this was my 1st conference as an attending! Happy I got to meet many of you! Already excited for #ACR23 #ChooseRheum
Tweet media one
Tweet media two
1
2
53
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 COVID-19 Vaccine Guidelines for #Immunocompromised Individuals 💉 🌟 New Bivalent Booster Recommendations per CDC ⬇️ Thanks Dr. Rebecca Sadun for review! #MedTwitter #RheumTwitter #OncTwitter
Tweet media one
0
31
55
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Honored to speak today at #DukeRheum Division Grand Rounds on Use of Digital #MedEd and Infographics in Rheumatology!
Tweet media one
3
2
53
@MithuRheum
Mithu Maheswaranathan, MD
2 years
@rabihmgeha @DxRxEdu To evaluate for any signs of skin thickening to suggest scleroderma! #Scleroderma renal crisis can present with MAHA and AKI ⬇️
@RheumOnePagers
Rheum OnePagers
2 years
🆕 Let’s learn about Scleroderma Renal Crisis, an important complication of #scleroderma to recognize as it is a medical emergency! 🚨 #RheumTwitter #NephTwitter #MedTwitter #MedEd
Tweet media one
3
163
428
0
3
52
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Part 2: Clinical Year in Review #ACR23
Tweet media one
0
26
51
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Excited to present my work and also see more #HealthLiteracy abstracts presented this year at #ACR21 🎉 #ACRAmbassador @ACRheum
Tweet media one
2
10
50
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Fact Sheet: COVID-19 Vaccines for Patients with Rheumatic Diseases 💉 Thank you Dr. Rebecca Sadun for reviewing the infographic! #COVID19Vaccine #Rheumatology
Tweet media one
Tweet media two
2
19
49
@MithuRheum
Mithu Maheswaranathan, MD
10 months
Around 33% of academic physicians report intention to leave their jobs in the next 2 years! 📊 Rheumatology Specific Data (n=102) • Intention to Leave 35% • Professional Fulfillment ~33% • Burnout Present ~40% Suspect not surprising data to many of us in #Rheumatology #MedX
Tweet media one
@JAMANetworkOpen
JAMA Network Open
10 months
1 in 3 academic physicians report they are considering leaving their institution within 2 years. Burnout and lack of professional fulfillment were associated with intention to leave; a comprehensive approach will be needed to reduce physician turnover.
22
255
697
9
9
48
@MithuRheum
Mithu Maheswaranathan, MD
3 years
CDC ACIP recommend today for #immunocompromised individuals to receive an additional 3rd (���booster”) dose of Pfizer or Moderna mRNA COVID-19 vaccines after completing the primary series: • same mRNA vaccine as primary series, if possible • at least 28 days after primary 💉
Tweet media one
Tweet media two
2
16
45
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Please share to increase public awareness about #ColorectalCancer ! Knowledge of symptoms can save lives. Thank you @drfolamay for reviewing my infographic. #GITwitter #ColonCancerAwareness #MedTwitter
Tweet media one
1
22
44
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Confused about ANAs? Check out the latest episode on @COREIMpodcast ! ✅ Interpreting +ANAs (Titer/Pattern) ✅ Ordering ANAs: when to order and when *not* to! ✅ Understanding the Broad DDx for a +ANA Had so much fun working on & recording this! #Rheumatology
@COREIMpodcast
CORE IM
2 years
1/ 🚨 New Episode🚨 ANA (Antinuclear Antibody) Test: #5Pearls Segment What does the titer mean? Is the pattern of the ANA helpful? What is the #ddx for a positive ANA? 🎧: Show Notes: Sponsor:
Tweet media one
5
95
337
1
17
42
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 ACR/VF 2021 Guidelines for Treatment & Management of #Vasculitis Part 2: ANCA Associated Vasculitis 🔗:
Tweet media one
1
18
40
@MithuRheum
Mithu Maheswaranathan, MD
1 year
Want to use infographics & visual/graphical abstracts for research, medical education & w/ patients? Join us for our talk at #ACR23 ! 🗣️ “Harnessing the Power of Graphics for Presentations, Publications & Education” 🎨 📆 Tues Nov 14, 4-5p PT 👥 w/ @AriellaStudies
Tweet media one
4
6
42
@MithuRheum
Mithu Maheswaranathan, MD
2 years
“You don’t have to look like or speak like the majority to make an impact. Understand and embrace your superpower. No one can be a better you than you” — @ShreyaTrivediMD This resonated *so* much with me - at #iMED2022 via @tony_breu
Tweet media one
2
2
41
@MithuRheum
Mithu Maheswaranathan, MD
3 years
After this visual abstract was released, we had many patient inquiries for an explanation of these results! 🔗: Plain Language Summary ⬇️ … Thanks coauthors @kristenyoung @RichAHoward & @alhkim for Review! @rheum_covid @COVaRiPAD @ACRheum @CreakyJoints
@MithuRheum
Mithu Maheswaranathan, MD
3 years
Visual Abstract for the #COVaRiPAD Study PrePrint by @alhkim & Team 💉 Humoral Responses after both doses of mRNA-based COVID-19 Vaccines in 133 Patients with Chronic Inflammatory Diseases (CID) #MedTwitter #RheumTwitter #Immunology #VisualAbstract
Tweet media one
11
59
139
5
15
41
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Rheum: +ANA ≠ autoimmune disease
@AdairaLandryMD
Adaira Landry, MD MEd
2 years
Question for #medtwitter : what is a tip related to your speciality that can help people have a healthier 2023? For EM, never drive while intoxicated.
730
711
4K
0
4
39
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕 CDC Guidance on COVID-19 Vaccines for Children <18 yrs who are Immunocompromised 👧🏾👦💉 Updated 10/2022 with New Bivalent Booster Vaccine Recommendations💉 Thank you, Dr. Rebecca Sadun for review!  #PedsTwitter #PedsRheum
Tweet media one
1
23
37
@MithuRheum
Mithu Maheswaranathan, MD
4 months
Tweet media one
1
4
38
@MithuRheum
Mithu Maheswaranathan, MD
2 years
🆕🌟CDC Guidance on COVID-19 Vaccines for Children <18 yrs who are Immunocompromised 👦👧🏾💉⬇️ Thank you Dr. Rebecca Sadun for reviewing! #PedsTwitter #PedsRheum #Pediatrics
Tweet media one
1
19
34
@MithuRheum
Mithu Maheswaranathan, MD
4 years
🆕 Commentary on Creating a #Lupus Patient Education Event, which I helped create as a med student @MUSChealth #HealthLiteracy #PatientEducation 🐺Top 3 Requested Topics: 1️⃣ Fatigue, Fibromyalgia, Depression 2️⃣ Lupus Medications 3️⃣ Understanding Labs
Tweet media one
3
4
35
@MithuRheum
Mithu Maheswaranathan, MD
2 months
Had fun speaking today at the 2024 NC LFA Lupus Educational Summit with @DrCassySims 🦋 We spoke about 💫 Menopause & Aging w/ SLE 💫 Understanding Lupus Labs 🧪 #Lupus @LupusNC @LupusOrg #SLE
Tweet media one
Tweet media two
0
0
35
@MithuRheum
Mithu Maheswaranathan, MD
3 years
@emily_fri Here is a fun table summarizing the different ANCAs & causes of x-ANCA (atypical) made by myself and @nickmmark for our PRS OnePager ⬇️
Tweet media one
2
8
34
@MithuRheum
Mithu Maheswaranathan, MD
1 year
Excited to collaborate with @theMednet on a special conversation around ACR Guidelines for Management of Reproductive Health in Rheumatic and MSK Diseases! Four #ReproRheum experts are ready to answer your Qs - post them on ! 🤰🏽 @melbussey @RheumDr_Nina
@MithuRheum
Mithu Maheswaranathan, MD
1 year
🆕 2020 ACR Guidelines for Management of Reproductive Health in Patients w/ Rheum & MSK Diseases 🤰🏽 🔸 Pregnancy Counseling 🔸 Meds in Pregnancy/Breastfeeding 🔸 Male Medication Safety for Conception #RheumTwitter #OBTwitter #ReproRheum #MedX
Tweet media one
5
76
181
0
9
35
@MithuRheum
Mithu Maheswaranathan, MD
2 years
Excited to announce @RheumOnePagers will be collaborating with #RheumMadness this year! 🎧Bracket Infographic Coming Soon💫 @DavidLeverenz @GuyKatzMD
1
7
34
@MithuRheum
Mithu Maheswaranathan, MD
11 months
For any fellows-in-training at #ACR23 interested, l’ll be hosting FIT roundtables on how to create more effective posters and presentations using graphics 🎨 Hope to see some of you there #RheumTwitter ! ⏰ 345pm-525pm PST 🗺️ Location: Room 29A-D
Tweet media one
0
4
33
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Congratulations @ACBarrMD on a fantastic oral presentation on factors associated with medication non-adherence in SLE #DukeRheum #ACR20 #Lupus #HealthDisparities
Tweet media one
Tweet media two
2
3
33
@MithuRheum
Mithu Maheswaranathan, MD
2 years
@rabihmgeha @DxRxEdu Non-Infectious Fever 🤒 • very high ferritin → should at least consider HLH/MAS • periodic fevers → consider autoinflammatory syndromes • evaluate for other s/sx → some rheumatic diseases present with fever like SLE or sarcoidosis; have seen ANCA vasculitis present as FUO
4
5
32
@MithuRheum
Mithu Maheswaranathan, MD
3 years
🆕 Updated 2022 ACR Guidance for Adjusting Immunomodulatory Therapy with the COVID-19 Vaccine in Patients with Rheumatic & MSK Diseases Version 5 Update (February 2022) ▼
Tweet media one
0
14
31
@MithuRheum
Mithu Maheswaranathan, MD
3 years
@ETSshow I enjoy creating infographics on topics in #Rheumatology 🎨
Tweet media one
Tweet media two
2
4
32
@MithuRheum
Mithu Maheswaranathan, MD
2 years
@BrownHospMed @AshimaMakol VEXAS Syndrome ⬇️
@MithuRheum
Mithu Maheswaranathan, MD
4 years
Learn about #VEXAS , a new adult-onset autoinflammatory syndrome ⬇️ #MedTwitter #Rheumatology
Tweet media one
6
61
169
0
7
31
@MithuRheum
Mithu Maheswaranathan, MD
1 month
🦋 New Visual Abstract with @HealioRheum 🟢 • Environmental factors that may contribute to #lupus are poorly understood • This study showed ⬆️ Ultraprocessed Food (UPF) Intake is associated with ⬆️ risk of developing SLE 📖 by Rossato et al 🔗:
Tweet media one
1
11
31
@MithuRheum
Mithu Maheswaranathan, MD
3 years
New ACR Guidance on 3rd COVID-19 Vaccine for #Rheumatology Providers!
@RheumOnePagers
Rheum OnePagers
3 years
🆕 2021 ACR COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic & MSK Diseases *Update* 8/19: Medication Adjustments with 3rd Dose (Booster) Vaccine ⬇️
Tweet media one
0
53
132
1
4
30
@MithuRheum
Mithu Maheswaranathan, MD
2 years
@rabihmgeha @DxRxEdu Rheumatology conditions associated with malignancy: • dermatomyositis • scleroderma (especially RNA pol III +) • Sjogren’s (lymphoma) • RS3PE (Great Q during #ACR22 )
0
3
30
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Update: I made an error and forgot to include all 3 speakers on the original graphic, in my speed to release this at #ACR23 ! My apologies to Dr. Marta Mosca, and thank you @AliDuarteMD for catching and notifying me of this mistake!
Tweet media one
0
12
29
@MithuRheum
Mithu Maheswaranathan, MD
11 months
Duke Rheumatology is excited to participate in the upcoming #ACR23 Here are some highlights from our division at the conference this year 🔽 @ACRheum #DukeRheum
Tweet media one
1
5
27
@MithuRheum
Mithu Maheswaranathan, MD
4 years
🎤 @selenagomez speaks at the #LupusResearchAlliance2020 about living with #lupus and the importance of lupus research! @LupusResearch #SelenaGomez
Tweet media one
0
3
26
@MithuRheum
Mithu Maheswaranathan, MD
2 months
Had an amazing time watching @DGlaucomflecken & @LGlaucomflecken live with #DukeRheum friends at their first stop of their 2024 Tour, “Wife and Death” 🎭 Such an incredibly funny & moving show evoking so many emotions with powerful messages…strongly recommend!!! 🥇
Tweet media one
Tweet media two
0
1
27